20,091 unvested stock units and three option lots comprise Corteva (CTVA) technology chief's holdings.
Corteva, Inc.'s Chief Technology Officer, Reza J. Rasoulpour, reported direct holdings of 20,091 unvested common stock units and three lots of non-qualified options. These options cover 10,248, 13,340, and 11,854 common shares, with exercise prices ranging from $8.67 to $10.28. While some options are already exercisable, the remaining portions are set to vest through February 18, 2028.
Corteva to End Pesticide Loyalty Program in FTC Deal
Corteva Inc. has agreed to dismantle its pesticide loyalty program and face a decade of restrictions on similar distributor incentives as part of a settlement with the Federal Trade Commission and state attorneys general. This agreement resolves claims from a 2022 lawsuit, which alleged Corteva used payments to discourage distributors from purchasing lower-cost generic pesticides after its patents expired, thereby limiting competition and keeping prices artificially high for farmers. The settlement aims to increase farmers' access to more affordable generic crop-protection products by fostering greater distributor freedom.
CPI | Pesticide Giant Reaches $35 Million Antitrust Deal With FTC
Corteva Inc. has agreed to a $35 million settlement and a decade-long restriction on certain pesticide-distribution loyalty programs to resolve an antitrust case brought by Nebraska, federal regulators, and other states. The settlement ends litigation stemming from a 2022 lawsuit that accused Corteva of using loyalty arrangements to stifle competition from lower-priced generic crop-protection products, resulting in higher prices for farmers. Nebraska expects to receive over $10 million from the settlement, which aims to increase competition and reduce costs for farmers and consumers, though litigation continues against Syngenta Crop Protection AG for similar allegations.
Corteva remains a 'buy' as innovation offsets pressure on legacy products, BofA says
Bank of America (BofA) maintains its 'buy' rating on Corteva Inc (NYSE:CTVA) with an $18 price target, citing new product launches and anticipated tighter agriculture markets in 2027. The analyst believes Corteva's product pipeline will effectively broaden its portfolio and replace legacy products, despite potential sales pressure from competitors and older products. The company's exposure to the grain cycle and expected product launch momentum into 2028 are seen as supportive factors for future growth.
Vylor completes separation from Corteva, created to 'reimagine agriculture'
Vylor has completed its separation from Corteva Inc. and now boasts a $19 billion technology pipeline aimed at "reimagining agriculture." The company plans to launch 12 groundbreaking technology platforms in corn, soy, and wheat over the next decade, focusing on improving yields, disease resistance, and insect control. Vylor projects significant growth in net sales and licensing income, with CEO Chuck Magro emphasizing their commitment to addressing global challenges like food and energy security through advanced agricultural technology.
Corteva, Inc. Stock 12‑Month Price Target Raised to $15.28, Implies 28% Upside
Corteva, Inc. (CTVA) has seen its average price target raised by analysts from $15.08 to $15.28, suggesting a potential upside of approximately 28% from its recent closing price. The consensus rating for CTVA remains a "Buy" among 24 covering analysts.
Vylor Is Open for Business: What Changes for Europe’s Seed Sector
Vylor, the new advanced seed and genetics company spun off from Corteva, officially launched on October 1, 2026, aiming to become a global pureplay agricultural genetics platform. The company emphasizes innovation, including gene editing and expanding into new crops like hybrid wheat, and plans significant collaboration with other seed companies through licensing and technology partnerships under its new identity, Vylor One. Vylor's leadership stresses its complete independence from Corteva and its focus on providing competitive genetics and support to partners, rather than being visible to farmers through its own brands.
Corteva remains a 'buy' as innovation offsets pressure on legacy products, BofA says
Bank of America (BofA) has reiterated its 'buy' rating on Corteva Inc (NYSE:CTVA) with an $18 price target, driven by the company's new product launches and expectations of tighter agriculture markets in 2027. Corteva recently separated its seed business into Vylor, becoming a focused crop protection company. While BofA acknowledged potential pressure from competitors and the need for new products to offset sales of older ones, it views Corteva's product pipeline favorably and sees supportive trends in agricultural markets for 2027.
UBS Adjusts Chemours Price Target to $16 From $18, Maintains Neutral Rating
UBS has adjusted its price target for Chemours (CC) to $16, down from $18, while maintaining a Neutral rating on the stock. This update reflects a revised outlook from the analyst firm for the diversified chemicals company. The article notes that access to full details requires a subscription.
Corteva, Inc. (C1TV34) Company Information
This article provides detailed company information for Corteva, Inc. (C1TV34) including its exchange listings, key financial data, and the data sources used for analysis. It outlines the company's market capitalization, industry, sector, and various international stock exchange listings, along with the methodologies and analyst coverage for their reports.
BofA initiates Vylor stock with buy rating on seed market strength
BofA Securities has initiated coverage on Vylor Inc. (NYSE:VYLR) with a buy rating and a $78.00 price target, citing its strength in the seed market. Vylor, recently spun off from Corteva, is a leading North American corn and soybean producer with strong innovation and distribution. Mizuho also initiated coverage with an Outperform rating and a higher price target of $84.00, driven by projections for future financial performance and seed demand.
NetApp Stock Rides An 8-Day Winning Streak To A 17% Gain
NetApp (NTAP) stock has experienced an 8-day winning streak, gaining 17.3% and adding approximately $6.5 billion to its market value, now standing at $44.3 billion. This rally is largely stock-specific, as the S&P 500 saw a slight decline during the same period. While the company shows mixed fundamentals with above-median operating margins and below-median valuation multiples but also below-median revenue growth, its significant stock performance highlights the importance of strategic investment beyond single-company streaks.
Corteva, Inc. (CTVA) Company Information
This article provides detailed company information for Corteva, Inc. (CTVA), including key details like its ticker, exchange, market cap, and location. It also outlines the company's various exchange listings, the data sources used for its analysis (S&P Global Market Intelligence LLC), and lists the analysts covering the stock.
Corteva Splits in Two: What the Restructuring Means for Farmers and the Future of Ag Tech
Corteva has officially split into two independent companies: Corteva, Inc., focusing on crop protection, and Vylor Inc., specializing in advanced seed and genetics. This restructuring aims to sharpen the focus of each entity, allowing for accelerated innovation in their respective fields to address farming challenges. While Corteva remains in Indianapolis, Vylor, headquartered in Iowa, will pursue new yield-enhancing technologies, though the split faces a legal challenge regarding PFAS liabilities.
LU Stock Jumps As Lufax Executes 1-For-10 ADS Reverse Split
Lufax Holding Ltd (LU) is executing a 1-for-10 reverse ADS split on the NYSE, changing the ratio from 1 ADS for 2 ordinary shares to 1 ADS for 20, aimed at raising the per-ADS trading price and preserving its listing. Despite this technical move, the stock has been trading down by -12.6%, reflecting market skepticism about its profitability and growth amidst regulatory pressures in the Chinese consumer finance sector. The article suggests that while the reverse split may create short-term trading opportunities, it does not fundamentally improve the company's economics, and traders should approach post-split price action with strict risk limits.
Corteva, Inc. (CTVA) Stock forecasts
Morningstar has provided a report on Corteva, Inc. (CTVA), setting a fair value estimate of $20 after the spinoff of its seeds business, Vylor, in 2026. The report highlights Corteva's position as a pure-play crop protection company and a leader in developing new products like herbicides, insecticides, and fungicides.
An October 1 trading debut is expected for Vylor (NYSE: VYLR), the Corteva spin-off.
Vylor Inc. (VYLR), a spin-off from Corteva, is set to begin regular-way trading on the NYSE under the symbol "VYLR" on October 1, 2026, with its Form 10 registration statement now effective. Corteva stockholders of record as of September 24, 2026, will receive one Vylor common share for each Corteva common share they hold. The distribution is expected before 9:30 a.m. New York City time on the trading debut date.
ETON Stock Rises as Eton Pharmaceuticals Secures Impavido Rights
Eton Pharmaceuticals Inc. (ETON) stock rose by 7.45% following the company securing exclusive U.S. commercialization rights for Impavido capsules. This move strengthens Eton's rare-disease franchise by integrating Impavido into its existing support platform with expanded patient assistance and specialized distribution. Analysts maintain a positive outlook, citing strong revenue momentum and potential for further margin expansion, with a price target of $68–72 over 6–12 months.
16 states sue Corteva, Vylor over alleged PFAS liability transfer
Sixteen U.S. states have filed a lawsuit against Corteva's seed and genetics spinoff, Vylor, alleging that Corteva illegally transferred billions of dollars in assets to Vylor while leaving potential PFAS-related liabilities behind. The lawsuit, filed in an Indiana state court, claims this action could hinder states from recovering damages tied to PFAS contamination from former parent company DuPont. Corteva maintains the lawsuit is without merit and based on faulty claims.
Corteva Just Split in Two. Here’s What Shareholders Own Now
Agricultural giant Corteva (CTVA) completed a spin-off of its seed business into a new company, Vylor (VYLR), on October 1, 2026. This resulted in a perceived 83% stock price drop for Corteva, but shareholders now own stakes in both companies, with a combined value initially exceeding the pre-split Corteva stock price. The split aimed to separate the seed and crop protection businesses, though a lawsuit from 15 states and Guam alleges the spin-off is a fraudulent transfer to shield assets from PFAS creditor claims.
Chemours Company (The) (CC) Stock forecasts
The article provides a daily report from Argus, "Vickers Top Insider Picks," which identifies companies with significant insider purchase histories using a proprietary algorithm. It mentions that Chemours Company (CC) is among the picks for October 2, 2026. The report is part of a premium service offering exclusive insights for investors.
Synaptics Stock Rises After onsemi Revises Deal to $123 Per Share
Synaptics shares rose after onsemi revised its acquisition deal to $123 per share, valuing the transaction at $5.7 billion, down from $7 billion previously. The new all-cash structure is expected to be immediately accretive to onsemi's non-GAAP earnings per share and provides value certainty for Synaptics shareholders. The deal has received U.S. Federal Trade Commission approval and is anticipated to close by mid-2027.
Latham Advises on Corteva and Vylor’s US$1.4 Billion Exchange Offers and Consent Solicitations
Latham & Watkins represented the dealer managers in connection with Corteva, Inc. and Vylor, Inc.'s US$1.4 billion exchange offers and consent solicitations. This transaction supports Corteva’s completed spin-off of Vylor, its advanced seed and genetics business. The Latham team was led by Byron Rooney and Jenn Lan, with associates Jackie Stern and Jen Kim.
Corteva’s Market Cap Tumbles By Over $42B Today – CTVA Stock Hits Record Low
Corteva's market capitalization decreased by over $42 billion today, and its stock reached a record low following the spin-off of its seed and genetics business, Vylor. Corteva now operates as a pure-play crop protection company, projecting significant sales and EBITDA growth by 2029. Vylor, trading under VYLR, has an impressive technology pipeline and also anticipates substantial growth in net sales and operating EBITDA by 2029.
How Does Corteva, Vylor Stand After Spin-off?
Corteva, Inc. completed the spin-off of its seed and genetics business into Vylor Inc., making Corteva a pure-play global crop protection company. Both companies have outlined their financial projections and strategic plans for the coming years, including revenue growth, EBITDA targets, and new product pipelines. Corteva expects significant growth in its crop protection business, while Vylor plans major advancements in seed and genetics technology.
CTVA Stock Collapses As Vylor Spin-Off Triggers Massive Repricing
Corteva Inc. (CTVA) stock experienced a massive repricing, falling over 80% after completing the spin-off of its seed business into a new public company, Vylor. The plunge was triggered by a federal court's denial to block the separation and was exacerbated by an earlier $455 million PFAS settlement. Traders are now assessing CTVA's valuation without its seed operations, its remaining financials, and lingering environmental liabilities.
CTVA Plunges As Corteva Spin-Off Vylor Triggers Massive Repricing
Corteva Inc. (CTVA) shares have plummeted by over 84% following the spin-off of its seed business into a new public company, Vylor, a move that federal courts did not block. This event triggered a massive repricing of CTVA, shifting its valuation and market perception. The article details the financial implications, including a legal settlement, and provides technical and fundamental analysis for traders navigating the stock's new price regime.
Teradyne Stock Rallies As AI Test And Robotics Bets Accelerate
Teradyne Inc. (TER) stock rallied by 8.41% due to strong demand in AI chip-testing and strategic advancements in robotics and photonics. The company introduced new platforms like Magnum E2 for high-speed memory testing and Iris 100 for optical test systems, targeting AI data centers and AR microdisplays. Additionally, partnerships and a new cobot platform strengthen Teradyne's position in AI-powered industrial automation and the semiconductor buildout, indicating sustained growth potential for active traders.
ORBS Stock Draws “Moonshot” Attention On OpenAI Exposure
Eightco Holdings Inc. (NASDAQ: ORBS) stock is drawing "moonshot" attention due to its indirect exposure to OpenAI, as highlighted by Bitmine's increasing stake in the company. Bitmine initially disclosed a $91 million position, later raising it to $115 million, classifying ORBS as a high-risk, high-reward AI-linked speculative play. Despite ORBS being deeply unprofitable with a rich valuation, its strong balance sheet and Bitmine's backing make it a volatile but attractive option for short-term and momentum traders interested in AI and blockchain proxies.
Inari Keeps Win Over Corteva’s Herbicide Resistant Enzyme Patent
Inari Agriculture Inc. successfully defended an administrative tribunal's decision at the Federal Circuit to invalidate a patent held by Corteva unit Pioneer Hi-bred International Inc. The patent, which describes enzymes designed to make crops resistant to herbicides, was deemed by the tribunal to not meet the Patent Act’s enablement requirement. This ruling stems from testing submitted by Pioneer, which showed that only two out of eight patented enzymes exhibited the intended dual resistance.
CF Industries Holdings, Inc. (CF) Stock forecasts
Argus has lowered its target price for CF Industries Holdings, Inc. (CF) to $127.00. The company, a leading producer and distributor of nitrogen primarily for fertilizers, is currently priced at $115.04. The report was published on September 30, 2026.
MSTR Stock Rallies As Bitcoin Buying Spree Accelerates
MicroStrategy (MSTR) stock rallied by 4.49% following an accelerated Bitcoin buying spree, with the company acquiring an additional 1,665 BTC for $142.7 million at an average price of $85,681. This latest purchase brings their total Bitcoin holdings to 847,666 BTC, valued at approximately $63.95 billion. Despite aggressive spending, MicroStrategy maintains strong liquidity with $5.0 billion in USD reserves and $1.0 billion in cash, demonstrating its commitment to a Bitcoin-centric strategy that is driving significant stock momentum.
Morgan Stanley raises Corteva stock price target on R&D pipeline strength
Morgan Stanley has raised its price target for Corteva Inc. (NYSE:CTVA) and maintained an Overweight rating, citing the strength of its R&D pipeline. The firm projects this pipeline to generate significant incremental revenue by 2030 and 2038, counteracting challenges from generic competition and product obsolescence. Despite a recent credit downgrade by S&P Global Ratings due to its seed business spin-off, other analysts like Mizuho, Oppenheimer, and KeyBanc remain positive on Corteva's future growth prospects.
Farmer Fertilizer Focus - October '25 UAN Video
This article features a video by Josh Linville, Vice President of Fertilizer, providing insights for October '25 on UAN. It is part of the "Farmer Fertilizer Focus" series from StoneX, offering expert analysis on commodities. The content emphasizes that the views expressed are opinions and not individualized recommendations.
Effort to block Vylor-Corteva separation fails as Johnston HQ opens
A federal court denied a last-minute request led by California and other states to block Corteva Agriscience from spinning off its seed business into Vylor Inc. The states alleged the separation was an attempt to avoid liability for PFAS "forever chemicals" related to Corteva's predecessor, DuPont. Vylor Inc. has now established its headquarters in Johnston, and its shares began trading on the NYSE.
Vylor, Inc. (VYLR) Stock Price, News, Quote & History
This article provides comprehensive financial data for Vylor, Inc. (VYLR), including its stock price, historical performance, key financial metrics, and analyst ratings. As of October 2nd, Vylor Inc. closed at $67.26, with an overnight price of $67.51. The company, founded in 1802, specializes in seed and genetics within the financial services sector.
Corteva stock adjusts following court clearance of Vylor Inc. separation
A U.S. District Court has denied California's motion to block Corteva Inc.'s planned spinoff of its seed business into Vylor Inc., clearing the way for the corporate separation. This marks the second denial of California's attempt to temporarily halt the separation. The article suggests this development will lead to adjustments in Corteva's stock.
Nike, Corteva, Mattel, Accenture and Coherent: Why These 5 Stocks Are on Investors' Radars Today
Global bonds experienced renewed selling pressure, driving borrowing costs in the U.S., France, and Japan to multi-decade highs, fueled by inflation and growth expectations. Despite this, major U.S. indices ended higher on Thursday. This article highlights five stocks—Nike, Corteva, Mattel, Accenture, and Coherent—that captured investor attention due to their recent earnings, strategic moves, or market-specific developments.
How Risky Is Home Depot Stock?
Home Depot's stock has fallen 12.6% in the last month without clear company news, and its operating margin has declined over the past three years, making it less profitable than before. While the stock has historically recovered from market shocks, its current lower profitability and exposure to a slow housing market suggest a potentially riskier outlook. Investors should consider these factors when evaluating Home Depot's resilience in future market downturns.
Corteva to pay $35 million after allegedly blocking farmers' access to cheaper pesticides
Corteva has agreed to a $35 million settlement with 12 states and the Federal Trade Commission, ending its crop loyalty program which allegedly blocked farmers' access to cheaper generic pesticides. The settlement requires Corteva to cease certain practices, cooperate in a similar ongoing lawsuit against Syngenta, and send compliance reports. While the money could potentially go to farmers as restitution, it is not guaranteed.
Vylor Takes Corteva’s S&P 500 Seat, Twilio Set To Replace Warner Bros. Discovery — Both Stocks Rise After-Hours
Vylor and Twilio are set to join the S&P 500, with Vylor replacing Corteva and Twilio replacing Warner Bros. Discovery. This move caused both Vylor (VYLR) and Twilio (TWLO) stock prices to rise in after-hours trading as index funds will be required to purchase their shares. Several other companies, including Corteva, Olin, Qorvo, FormFactor, and Workiva, are also undergoing index reallocations as a result of these changes and various mergers and acquisitions.
Corteva to Join S&P MidCap 400 Following Vylor Spinoff
Corteva (CTVA) is set to replace Olin Corp (OLN) in the S&P MidCap 400 index. This change will occur before the opening of trading and follows Corteva's Vylor spinoff. The article indicates that accessing the full details requires a premium subscription.
States sue over Corteva's Vylor spinoff, citing PFAS liabilities
Sixteen states and territories are suing Corteva and its new spinoff, Vylor, alleging that Vylor received significant assets from the former DuPont without assuming any of its PFAS environmental liabilities. The lawsuit claims Corteva spun off Vylor to shield it from these costly obligations related to per- and polyfluoroalkyl substances.
Twilio to join S&P 500 as S&P Dow Jones reshuffles indices
S&P Dow Jones Indices announced several benchmark rebalancings, effective prior to market open on Tuesday, Oct. 6, driven by corporate M&A and capital structure changes. Twilio Inc. (NYSE:TWLO) will join the S&P 500, replacing Warner Bros Discovery Inc. (NASDAQ:WBD), which is being acquired. Additionally, FormFactor Inc. (NASDAQ:FORM) moves to the S&P MidCap 400, and Workiva Inc. (NYSE:WK) joins the S&P SmallCap 600.
CTVA Stock Drops As $455M PFAS Settlement Hits Sentiment
Corteva Inc. (CTVA) stock dropped 4.5% following news of a $455 million PFAS-related settlement with North Carolina, shared with Chemours and DuPont. Despite the negative headline, the company's strong balance sheet and consistent revenue suggest it can absorb the cost, leading to a controlled slide rather than a collapse. Traders are now watching for stabilization within the $77-$83 range, indicating that dip buyers are active even as legal risk caps upside momentum.
Why Is Corteva Stock Sinking Thursday?
Corteva Inc. (NYSE: CTVA) stock plummeted by about 82% after completing the spin-off of its seed and genetics business into Vylor Inc. (NYSE: VYLR). This significant decline primarily reflects the transfer of Vylor's value out of Corteva, not a destruction of shareholder value, making direct comparisons to pre-separation levels difficult. Following the separation, Corteva will operate as a pure-play global crop protection business, while Vylor has taken on existing debt and will trade separately.
Corteva Separation Into Two Companies Expected to Proceed October 1 After Court Ruling
Corteva, Inc. announced its planned separation into two independent publicly traded companies is expected to proceed on October 1, 2026, after a court ruling cleared the way. The separation involves spinning off Corteva's seed operating segment into a new independent company, Vylor Inc. A US Court of Appeals reversed a district court order that had initially denied California's motion to block the separation, and following a remand, the district court denied California's motion, allowing the transaction to move forward.
Corteva Begins New Chapter as Focused, Innovation-Led, Global Crop Protection Leader
Corteva, Inc. announced its successful spin-off of its advanced seed and genetics business, transforming into a pure-play global crop protection company. The company emphasizes its strong momentum, robust $11 billion pipeline, and commitment to innovation, including 12 new actives and 5 biologicals planned for launch in the next decade. Corteva aims to deliver safe, effective, and sustainable solutions for farmers, leveraging its expanded operating EBITDA margins and an industry-leading biologicals platform.
S&P 500 Futures Climb in Premarket Trading; Corteva, Sun Life Financial Lag
S&P 500 futures showed gains in premarket trading. Among individual stocks, Accenture PLC Cl A (ACN) rose significantly by 17.3%, and Vicor Corp. (VICR) was up 11.9% before the market opened. The article also notes that Corteva and Sun Life Financial were lagging.
RBC Capital Sticks to Its Hold Rating for Dow Inc (DOW)
RBC Capital has maintained its Hold rating on Dow Inc (DOW) with a price target of $29.00, following the company's shares closing at $27.61. Analyst Arun Viswanathan, who covers the Basic Materials sector, issued the report. Citi also downgraded the stock to a Hold with a $30.00 price target. Dow Inc reported a quarterly revenue of $12.09 billion and a net profit of $721 million for the quarter ending June 30.
